Fusion Family Wealth LLC Biogen Inc. Transaction History

Fusion Family Wealth LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$259.0 - $414.71 $1,554 - $2,488	-6 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $2,912 - $3,362	-11 Reduced 64.71%	6 $2,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $2,586 - $3,425	-10 Reduced 37.04%	17 $5,000
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $5,645 - $7,161	21 Added 350.0%	27 $9,000
Q4 2019 Jan 29, 2020	SELL	$220.06 - $304.07 $19,585 - $27,062	-89 Reduced 93.68%	6 $2,000
Q3 2019 Oct 31, 2019	BUY	$217.44 - $243.88 $6,740 - $7,560	31 Added 48.44%	95 $22,000
Q2 2019 Aug 06, 2019	BUY	$219.29 - $241.72 $12,718 - $14,019	58 Added 966.67%	64 $15,000
Q1 2019 May 10, 2019	SELL	$216.71 - $338.96 $12,569 - $19,659	-58 Reduced 90.63%	6 $1,000
Q4 2018 Jan 18, 2019	SELL	$278.5 - $352.75 $41,775 - $52,912	-150 Reduced 70.09%	64 $19,000
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $61,050 - $79,836	208 Added 3466.67%	214 $76,000
Q2 2017 Aug 07, 2017	BUY	N/A	6	6 $2,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Fusion Family Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Fusion Family Wealth LLC with notifications on news.